Others have reported that overexpression of AP-2α inhibits breast cancer cell growth by inducing the expression of the cell cycle inhibitor p21, repressing cyclin D1, decreasing Rb phosphorylation, and by enhancing E2F activity [29]. The gene discussed is CCND1; the disease is breast cancer.